MedTrace Logo

Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

NCT01349361 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2011-05-06

No results posted yet for this study

Summary

Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC.

Conditions

  • Photodynamic Therapy
  • Basal Cell Carcinomas

Interventions

PROCEDURE

Daylight mediated photodynamic therapy

Sponsors & Collaborators

  • Bispebjerg Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2013-01-31

Countries

  • Denmark

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01349361 on ClinicalTrials.gov